Fengxia Lin
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Sulfur Compounds in Biology
Papers in
-
- Ginseng Biological Effects and Applications 2
- Inflammasome and immune disorders 2
-
- Biological and pharmacological studies of plants 2
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- Yinzhi Song (12 shared papers)Ke Xiao (2 shared papers)Xiaojing Huang (2 shared papers)Zijun Wu (2 shared papers)Yiying Yang (1 shared paper)Bin Deng (3 shared papers)Xiao Ke (1 shared paper)Xun Hu (1 shared paper)
- Journals
- Frontiers in Nutrition (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Drug Design Development and Therapy (2 papers)Journal of Pharmacy and Pharmacology (1 paper)Journal of Biomaterials Applications (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Fengxia Lin
21 papers receiving 374 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 106
- Biochemistry 36
- Pharmacology 39
- Complementary and alternative medicine 36
- Molecular Biology 216
Countries citing papers authored by Fengxia Lin
This map shows the geographic impact of Fengxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Lin more than expected).
Fields of papers citing papers by Fengxia Lin
This network shows the impact of papers produced by Fengxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Lin. The network helps show where Fengxia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 92 | |
| 2 | 2020 | 91 | |
| 3 | 2020 | 31 | |
| 4 | 2019 | 26 | |
| 5 | 2018 | 22 | |
| 6 | 2020 | 20 | |
| 7 | 2022 | 20 | |
| 8 | 2024 | 17 | |
| 9 | 2016 | 16 | |
| 10 | 2020 | 12 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2016 | 5 | |
| 15 | 2022 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2018 | 1 |
About Fengxia Lin
Fengxia Lin is a scholar working on Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 380 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Biological and pharmacological studies of plants (2 papers), Ginseng Biological Effects and Applications (2 papers), Wound Healing and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Inflammasome and immune disorders (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Cancer Research (106 citations), Biochemistry (36 citations), Pharmacology (39 citations), Complementary and alternative medicine (36 citations) and Molecular Biology (216 citations). Fengxia Lin has collaborated with scholars based in China and South Korea. Frequent co-authors include Yinzhi Song, Ke Xiao, Xiaojing Huang, Zijun Wu, Yiying Yang, Bin Deng, Xiao Ke, Xun Hu, Zhiwen Li and Liang Li. Their work appears in journals such as Frontiers in Nutrition, Evidence-based Complementary and Alternative Medicine, Drug Design Development and Therapy, Journal of Pharmacy and Pharmacology and Journal of Biomaterials Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.